CollPlant Biotechnologies Ltd Sustainability Reports

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company that develops plant-based technologies for tissue repair and organ manufacturing. The company produces recombinant human collagen (rhCollagen) utilized in 3D bioprinting applications and medical aesthetics.

Sector: Manufacturing

Country: Israel

Exchange: Nasdaq

FIGI: BBG008754SP0

10 reports from 2017 to 2025

• CollPlant Biotechnologies Ltd 2025 Form 20-F
• CollPlant Biotechnologies Ltd 2024 Form 20-F
• CollPlant Biotechnologies Ltd 2023 Annual Report
• CollPlant Biotechnologies Ltd 2023 Sustainability Report
• CollPlant Biotechnologies Ltd 2022 Form 20-F